PT561073E - Tratamento da hipertensao ocular com beta-bloqueadores e derivados de acido prostanoico - Google Patents

Tratamento da hipertensao ocular com beta-bloqueadores e derivados de acido prostanoico

Info

Publication number
PT561073E
PT561073E PT92307700T PT92307700T PT561073E PT 561073 E PT561073 E PT 561073E PT 92307700 T PT92307700 T PT 92307700T PT 92307700 T PT92307700 T PT 92307700T PT 561073 E PT561073 E PT 561073E
Authority
PT
Portugal
Prior art keywords
beta
treatment
ocular hypertension
blockers
derivatives
Prior art date
Application number
PT92307700T
Other languages
English (en)
Inventor
Ryuji Ueno
Sachiko Kuno
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Publication of PT561073E publication Critical patent/PT561073E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT92307700T 1992-03-19 1992-08-24 Tratamento da hipertensao ocular com beta-bloqueadores e derivados de acido prostanoico PT561073E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6331692 1992-03-19

Publications (1)

Publication Number Publication Date
PT561073E true PT561073E (pt) 2002-04-29

Family

ID=13225754

Family Applications (1)

Application Number Title Priority Date Filing Date
PT92307700T PT561073E (pt) 1992-03-19 1992-08-24 Tratamento da hipertensao ocular com beta-bloqueadores e derivados de acido prostanoico

Country Status (9)

Country Link
US (1) US5432174A (pt)
EP (1) EP0561073B1 (pt)
JP (1) JPH0640919A (pt)
AT (1) ATE207360T1 (pt)
DE (1) DE69232150T2 (pt)
DK (1) DK0561073T3 (pt)
ES (1) ES2166353T3 (pt)
GR (1) GR3037008T3 (pt)
PT (1) PT561073E (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06107547A (ja) * 1992-10-01 1994-04-19 Aarutetsuku Ueno:Kk 眼科用組成物
US5721273A (en) * 1993-12-15 1998-02-24 Alcon Laboratories, Inc. Use of certain 9-halo-13,14-dihydroprostaglandins to treat glaucoma and ocular hypertension
US5627209A (en) * 1993-12-15 1997-05-06 Alcon Laboratories, Inc. Use of certain 9-haloprostaglandins to treat glaucoma and ocular hypertension
US5545665A (en) * 1993-12-28 1996-08-13 Allergan Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents
US5807892A (en) * 1994-09-30 1998-09-15 Alcon Laboratories, Inc. Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
US5698733A (en) * 1994-09-30 1997-12-16 Alcon Laboratories, Inc. Use of 9-deoxy prostaglandin derivatives to treat glaucoma
AU7672096A (en) 1995-06-07 1998-06-03 Alcon Laboratories, Inc. Conformationally rigid aryl- or heteroaryl prostaglandins for use in glaucoma therapy
US5814660A (en) * 1995-12-22 1998-09-29 Alcon Laboratories, Inc. 9-oxa prostaglandin analogs as ocular hypotensives
US5866602A (en) * 1995-12-22 1999-02-02 Alcon Laboratories, Inc. Keto-substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
EP0944593A2 (en) 1996-11-12 1999-09-29 Alcon Laboratories, Inc. $i(CIS)-$g(D)?4 ANALOGS OF PROSTAGLANDINS AS OCULAR HYPOTENSIVES
US6680339B2 (en) 1996-11-12 2004-01-20 Alcon Manufacturing, Ltd. 15-fluoro prostaglandins as ocular hypotensives
WO1998020881A1 (en) 1996-11-12 1998-05-22 Alcon Laboratories, Inc 15-ketal prostaglandins for the treatment of glaucoma or ocular hypertension
AU5355498A (en) 1996-11-12 1998-06-03 Alcon Laboratories, Inc. 15-fluoro prostaglandins as ocular hypotensives
ES2265166T3 (es) * 1997-10-13 2007-02-01 R-Tech Ueno, Ltd. Composicion para tratamiento de hipertension intraocular o glaucoma.
AU1709699A (en) 1997-12-22 1999-07-12 Alcon Laboratories, Inc. 13-oxa prostaglandins for the treatment of glaucoma and ocular hypertension
US6417228B1 (en) 1998-11-02 2002-07-09 Alcon Manufacturing, Ltd.. 13-Aza prostaglandins for the treatment of glaucoma and ocular hypertension
AU1607100A (en) 1998-11-06 2000-05-29 Alcon Laboratories, Inc. Upregulation of endogenous prostaglandins to lower intraocular pressure
US6096783A (en) * 1998-12-15 2000-08-01 Alcon Laboratories, Inc. Cyclobutane prostaglandin analogues as ocular hypotensive agents
US6160013A (en) * 1998-12-17 2000-12-12 Alcon Laboratories, Inc. 14-aza prostaglandins for the treatment of glaucoma and ocular hypertension
US6211226B1 (en) 1998-12-17 2001-04-03 Alcon Laboratories, Inc. 11-Aza prostaglandins for the treatment of glaucoma and ocular hypertension
AU2211700A (en) 1998-12-24 2000-07-31 Alcon Laboratories, Inc. Prostaglandin e agonists for treatment of glaucoma
WO2000038663A2 (en) 1998-12-24 2000-07-06 Alcon Laboratories, Inc. Ep4 receptor agonists for treatment of dry eye
WO2001046134A1 (en) 1999-12-22 2001-06-28 Alcon Universal Ltd. 6-KETO PROSTAGLANDIN F1α AND ANALOGS FOR TREATING DRY EYE
US20020133009A1 (en) * 2001-03-13 2002-09-19 Lambrou George N. Method for opening potassium channels
JP2004529177A (ja) * 2001-05-14 2004-09-24 スキャンポ・アーゲー 高眼圧症および緑内障の処置方法
US20040225014A1 (en) * 2003-02-14 2004-11-11 Sucampo Ag Method for treating ocular hypertension and glaucoma
TWI348386B (en) * 2003-08-12 2011-09-11 R Tech Ueno Ltd Composition and method for promoting hair growth
BRPI0414149A (pt) * 2003-09-05 2006-10-31 Novartis Ag composições compreendendo derivados de benzo(g)-quinolina e derivados de prostaglandina
US20090148527A1 (en) * 2007-12-07 2009-06-11 Robinson Michael R Intraocular formulation
UY30883A1 (es) 2007-01-31 2008-05-31 Alcon Res Tapones punctales y metodos de liberacion de agentes terapeuticos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0286903B2 (en) * 1987-04-03 2000-03-29 The Trustees Of Columbia University In The City Of New York Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
US4952581A (en) * 1987-04-03 1990-08-28 The Trustees Of Columbia University In The City Of New York Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
US5166175A (en) * 1990-05-22 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Treatment of ocular hypertension with a synergistic combination

Also Published As

Publication number Publication date
EP0561073B1 (en) 2001-10-24
ATE207360T1 (de) 2001-11-15
DE69232150T2 (de) 2002-03-07
DE69232150D1 (de) 2001-11-29
GR3037008T3 (en) 2002-01-31
US5432174A (en) 1995-07-11
ES2166353T3 (es) 2002-04-16
DK0561073T3 (da) 2001-11-12
JPH0640919A (ja) 1994-02-15
EP0561073A1 (en) 1993-09-22

Similar Documents

Publication Publication Date Title
PT561073E (pt) Tratamento da hipertensao ocular com beta-bloqueadores e derivados de acido prostanoico
WO2000027424B1 (en) Upregulation of endogenous prostaglandins to lower intraocular pressure
HK1007102A1 (en) Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma
EP0105635A3 (en) Nonirritating aqueous ophthalmic compositions comfort formulation for ocular therepeutic agents
WO2002096432A3 (en) Hypotensive lipid (prostaglandin derivatives) and timolol compositions and methods of using same
TWI255713B (en) Method for treating meibomian gland disease
AU696851B2 (en) Method of treating hyperproliferative vascular disease
EP1514548A3 (en) Use of cloprostenol fluprostenol, and their analogues to treat glaucoma and ocular hypertension
RU93042471A (ru) Композиции, маскирующие горький вкус фармацевтических агентов, способ их получения, способ лечения
CA2107669A1 (en) Preparation for treating wounds and hemorrhoides
IE810785L (en) Anti-inflammatory ophthalmic composition
IL90551A0 (en) Stable,injectable,aqueous pharmaceutical compositions for the treatment of cardiac conditions
FR2630328B1 (fr) Derive de l'histamine, sa preparation et son application en therapeutique
KR910019621A (ko) 상승병용을 이용한 안고혈압 치료
ATE141506T1 (de) Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff
JO1195B1 (en) Pharmaceutical preparations for the treatment of cyanosis and ocular hypertension
DE69301387D1 (de) Behandlung des Glaukoms mit synergistischer Kombination
JPS6426518A (en) Remedy for hyperophthalmotony
AU5992786A (en) Increasing aqueous humor outflow
JPS5513241A (en) Remedy for glaucoma
CA2109572A1 (en) Method for reducing side-effects of a drug
WO1990006116A3 (de) Mittel zur behandlung von chronisch entzündlichen darmerkrankungen
ES2018939A6 (es) Procedimiento de preparacion de una composicion farmaceutica para uso oftalmico.
RU95106983A (ru) Офтальмологический состав, способ его получения и средство для офтальмологического состава
KR930700109A (ko) 신경 질환 치료용 4,4'-[9h-플루오렌-9-일리덴비스(메틸렌)]-비스피리미딘